Concise review: Stem cell-based approaches to red blood cell production for transfusion

Stem Cells Translational Medicine

Volumn 3, Issue 3, 2014, Pages 346-355

  Shah, Siddharth ^a   Huang, Xiaosong ^a   Cheng, Linzhao ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Erythropoiesis; Hematopoietic stem cells; Pluripotent stem cells; Red blood cell transfusion; Reticulocytes

Indexed keywords

HEMOGLOBIN;

ALLOIMMUNITY; ALLOIMMUNIZATION; BLOOD TRANSFUSION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENUCLEATION; ERYTHROCYTE TRANSFUSION; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PLURIPOTENT STEM CELL; REVIEW; UMBILICAL CORD;

ERYTHROPOIESIS; HEMATOPOIETIC STEM CELLS; PLURIPOTENT STEM CELLS; RED BLOOD CELL TRANSFUSION; RETICULOCYTES;

ANTIGENS, CD; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; ERYTHROCYTES; ERYTHROPOIESIS; FEEDER CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; ISOANTIGENS; PLURIPOTENT STEM CELLS; RETICULOCYTES;

EID: 84896275082     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0054     Document Type: Review

References (86)

1. World Health Organization. Global Database on Blood Safety: Summary report 2011. Available at http://www.who.int/entity/bloodsafety/global_ database/GDBS_Summary_Report_2011.pdf. Accessed September 8, 2012.
2. Adams RJ, McKie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
3. Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev 2008;22:53-63.
4. U.S. Census Bureau. Global population composition. Available at http://www.census. gov/population/international/files/wp02/wp-02004.pdf. Accessed September 14, 2012.
5. Ali A, Auvinen MK, Rautonen J. The aging population poses a global challenge for blood services. Transfusion 2010;50:584-588.
6. Daniels G, Castilho L, FlegelWAet al. International Society of Blood Transfusion Committee on terminology for red blood cell surface antigens: Macao report. Vox Sang 2009;96: 153-156.
7. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007;21:58-71.
8. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: Pathophysiology, risk factors, and transfusion management. Blood 2012;120: 528-537.
9. Reesink HW, Engelfriet CP, Schennach H et al. Donors with a rare pheno (geno) type. Vox Sang 2008;95:236-253.
10. Bagnis C, Chiaroni J, Bailly P. Elimination of blood group antigens: Hope and reality. Br J Haematol 2011;152:392-400.
11. Castro CI, Briceno JC. Perfluorocarbonbased oxygen carriers: Review of products and trials. Artif Organs 2010;34:622-634.
12. Silverman TA, Weiskopf RB. Hemoglobinbased oxygen carriers: Current status and future directions. Transfusion 2009;49:2495-2515.
13. Baron MH, Isern J, Fraser ST. The embryonic origins of erythropoiesis in mammals. Blood 2012;119:4828-4837.
14. Palis J. Ontogeny of erythropoiesis. Curr Opin Hematol 2008;15:155-161.
15. Sankaran VG, Xu J, Orkin SH. Advances in the understanding of haemoglobin switching. Br J Haematol 2010;149:181-194.
16. Chasis JA, Mohandas N. Erythroblastic islands: Niches for erythropoiesis. Blood 2008; 112:470-478.
17. Palis J, Segel GB. Developmental biology of erythropoiesis. Blood Rev 1998;12:106-114.
18. Rochette J, Craig JE, Thein SL. Fetalhemoglobin levels in adults. Blood Rev 1994;8: 213-224.
19. Kim CG, Epner EM, ForresterWCet al. Inactivation of the human b-globin gene by targeted insertion into the b-globin locus control region. Genes Dev 1992;6:928-938.
20. Sankaran VG, Orkin SH. The switch from fetal to adult hemoglobin. Cold Spring Harb Perspect Med 2013;3:a011643.
21. Zhou D, Liu K, Sun C-W et al. KLF1 regulates BCL11A expression and g-to b-globin gene switching. Nat Genet 2010;42:742-744.
22. Murphy PJ. The fetal circulation. Contin Educ Anaesth Crit Care Pain 2005;5:107-112.
23. Conley CL, Weatherall DJ, Richardson SN et al. Hereditary persistence of fetal hemoglobin: A study of 79 affected persons in 15 Negro families in Baltimore. Blood 1963;21: 261-281.
24. Weatherall DJ, Clegg JB. Hereditary persistence of fetal haemoglobin. Br J Haematol 1975;29:191-198.
25. Platt OS, Thorington BD, Brambilla DJ et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16.
26. Migliaccio AR. Erythroblast enucleation. Haematologica 2010;95:1985-1988.
27. Ubukawa K, Guo YM, Takahashi M et al. Enucleation of human erythroblasts involves non-muscle myosin IIB. Blood 2012;119:1036-1044.
28. Keerthivasan G, Small S, Liu H et al. Vesicle trafficking plays a novel role in erythroblast enucleation. Blood 2010;116:3331-3340.
29. Migliaccio AR, Whitsett C, Migliaccio G. Erythroid cells in vitro: From developmental biology to blood transfusion products. Curr Opin Hematol 2009;16:259-268.
30. Giarratana MC, Kobari L, Lapillonne H et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005;23:69-74.
31. Wang T-F, Chu S-C, Chen S-H et al. The effect of different harvest strategies on the nucleated cell yields of bone marrow collection. Biol Blood Marrow Transplant 2011;17:351-355.
32. Hao Q-L, Shah AJ, Thiemann FT et al. A functional comparison of CD34 + CD38-cells in cord blood and bone marrow. Blood 1995; 86:3745-3753.
33. Solves P, Carbonell-Uberos F, Mirabet V et al. CD34+ cell content for selecting umbilical cord blood units for cryopreservation. Transfusion 2007;47:552-553.
34. Csaszar E, Kirouac DC, Yu M et al. Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell 2012;10:218-229.
35. Boitano AE, Wang J, Romeo R et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010;329:1345-1348.
36. Hofmeister CC, Zhang J, Knight KL et al. Ex vivo expansion of umbilical cord blood stem cells for transplantation: Growing knowledge from the hematopoietic niche. Bone Marrow Transplant 2007;39:11-23.
37. Andrade PZ, Santos FD, Cabral JMS et al. Stem cell bioengineering strategies to widen the therapeutic applications of haematopoietic stem/progenitor cells from umbilical cord blood. J Tissue Eng Regen Med 2013 [E-pub ahead of print].
38. Bernstein ID, Delaney C. Engineering stem cell expansion. Cell Stem Cell 2012;10: 113-114.
39. Szabo E, Rampalli S, Risueno RMet al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010;468: 521-526.
40. Malik P, Fisher TC, Barsky LLW et al. An in vitro model of human red blood cell production from hematopoietic progenitor cells. Blood 1998;91:2664-2671.
41. Giarratana MC, Rouard H, Dumont A et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood 2011; 118:5071-5079.
42. Neildez-Nguyen TMA, Wajcman H, Marden MC et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002;20:467-472.
43. Fujimi A, Matsunaga T, KobuneMet al. Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by coculturing with macrophages. Int J Hematol 2008;87:339-350.
44. Baek EJ, Kim H-S, Kim S et al. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells. Transfusion 2008;48:2235-2245.
45. Miharada K, Hiroyama T, Sudo K et al. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol 2006;24: 1255-1256.
46. Timmins NE, Athanasas S, Günther M et al. Ultra-high-yield manufacture of red blood cells from hematopoietic stem cells. Tissue Eng Part C Methods 2011;17:1131-1137.
47. Foeken LM, Green A, Hurley CK et al. Monitoring the international use of unrelated donors for transplantation: The WMDA annual reports. Bone Marrow Transplant 2010;45: 811-818.
48. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
49. Takahashi K, Tanabe K, OhnukiMet al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
50. Ng ES, Davis RP, Azzola L et al. Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 2005;106:1601-1603.
51. Choi K-D, Yu J, Smuga-Otto K et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. STEM CELLS 2009;27:559-567.
52. Hiroyama T, Miharada K, Sudo K et al. Establishment of mouse embryonic stem cellderived erythroid progenitor cell lines able to produce functional red blood cells. PloS One 2008;3:e1544.
53. Qiu C, Olivier EN, Velho M et al. Globin switches in yolk sac-like primitive and fetallike definitive red blood cells produced from human embryonic stem cells. Blood 2008;111: 2400-2408.
54. Lu SJ, Feng Q, Park JS et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008;112: 4475-4484.
55. Lapillonne H, Kobari L, Mazurier C et al. Red blood cell generation from human induced pluripotent stem cells: Perspectives for transfusion medicine. Haematologica 2010;95:1651-1659.
56. Dias J, Gumenyuk M, Kang H et al. Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev 2011; 20:1639-1647.
57. Chang C-J, Mitra K, KoyaMet al. Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells. PLoS One 2011;6:e25761.
58. Kobari L, Yates F, Oudrhiri N et al. Human induced pluripotent stem cells can reach complete terminal maturation: In vivo and in vitro evidence in the erythropoietic differentiation model. Haematologica 2012;97:1795-1803.
59. Ran D, Shia W-J, Lo M-C et al. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood 2013;121: 2882-2890.
60. Feng Q, Lu S-J, Klimanskaya I et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. STEM CELLS 2010; 28:704-712.
61. Chang K-H, Nelson AM, Fields PA et al. Diverse hematopoietic potentials of five human embryonic stem cell lines. Exp Cell Res 2008; 314:2930-2940.
62. Peyrard T, Bardiaux L, Krause C et al. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: Potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev 2011;25:206-216.
63. Zou J, Mali P, Huang X et al. Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood 2011;118:4599-4608.
64. Hanna J, Wernig M, Markoulaki S et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007;318:1920-1923.
65. Bauer A, Tronche F, Wessely O et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 1999;13:2996-3002.
66. Leberbauer C, Boulmé F, Unfried G et al. Different steroids co-regulate long-termexpansion versus terminal differentiation in primary human erythroid progenitors. Blood 2005; 105:85-94.
67. von Lindern M, Zauner W, Mellitzer G et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 1999;94:550-559.
68. Migliaccio G, Di Pietro R, di Giacomo V et al. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis 2002;28:169-180.
69. Migliaccio G, Sanchez M, Masiello F et al. Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplant 2010;19:453-469.
70. Nakamura Y, Hiroyama T, Miharada K et al. Red blood cell production from immortalized progenitor cell line. Int J Hematol 2011;93: 5-9.
71. Kitamura T, Tange T, Terasawa T et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989;140:323-334.
72. Wong S, Keyvanfar K, Wan Z et al. Establishment of an erythroid cell line from primary CD36+ erythroid progenitor cells. Exp Hematol 2010;38:994-1005, e1-e2.
73. Nakamura Y. Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells. ISBT Sci Ser 2012;7:202-206.
74. Carotta S, Pilat S, Mairhofer A et al. Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells. Blood 2004;104:1873-1880.
75. England SJ, McGrath KE, Frame JM et al. Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus. Blood 2011;117:2708-2717.
76. Huang X, Shah S, Wang J et al. Extensive Ex Vivo Expansion of Functional Human Erythroid Precursors Established From Umbilical Cord Blood Cells by Defined Factors. Mol Ther 2013 (in press).
77. Yoshioka N, Gros E, Li HR et al. Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell 2013;13: 246-254.
78. Hou P, Li Y, Zhang X et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013; 341:651-654.
79. Chou BK, Mali P, Huang X et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 2011; 21:518-529.
80. Kurita R, Suda N, Sudo K et al. Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells. PLoS One 2013;8:e59890.
81. Zeuner A, Martelli F, Vaglio S et al. Concise review: Stem cell-derived erythrocytes as upcoming players in blood transfusion. STEM CELLS 2012;30:1587-1596.
82. Esteghamat F, Gillemans N, Bilic I et al. Erythropoiesis and globin switching in compound Klf1:Bcl11a mutant mice. Blood 2013; 121:2553-2562.
83. Bouhassira EE. Concise review: Production of cultured red blood cells from stem cells. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:927-933.
84. Timmins NE, Nielsen LK. Blood cell manufacture: Current methods and future challenges. Trends Biotechnol 2009;27:415-422.
85. Anstee DJ, Gampel A, Toye AM. Exvivo generation of human red cells for transfusion. Curr Opin Hematol 2012;19:163-169.
86. Wang Y, Chou B-K, Dowey SN et al. Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. Stem Cell Res (Amst) 2013;11:1103-1116.